You are here
- Home
- Drug Products
- All Drug Products
A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) When Given in Combination with Standard Doses of Selected Chemotherapies to Patients with Advanced Solid Tumors.
- Disease
- solid tumour
- Drug Name
- AZD6244
- Generic Name
- AZD6244
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Dec 14, 2007
- Study Name
- D1532C00004
- Study Id
- D1532C00004
- ClinicalTrials.gov ID
- NCT00600496
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
